(PDF) PND34 Cost-Utility Analysis of Lacosamide Adjunctive

PND34 Cost-Utility Analysis of Lacosamide Adjunctive Therapy in the Treatment of Patients With Refractory in the Slovak Republic

Value in Health - United Kingdom

doi 10.1016/j.jval.2011.08.500

Full Text

Abstract

Available in full text

Categories

Occupational Health

Date

November 1, 2011

Authors

Publisher

Elsevier BV

Related search

Pms50 - Cost-Effectiveness Analysis of Apremilast in the Treatment of Psoriatic Arthritis (Psa) in the Slovak Republic and Slovenia

Value in Health

Occupational Health

English

Pnd74 - Cost Utility Model of Brivaracetam in the Adjunctive Treatment for Partial-Onset Epileptic Seizures in Spain

Value in Health

Occupational Health

English

Efficacy and Tolerability of Lacosamide in the Concomitant Treatment of 130 Patients Under 16 Years of Age With Refractory Epilepsy

Drugs in R and D

English

Cost-Utility Analysis of Taxane Therapy

American Journal of Health-System Pharmacy

English

Clobazam as Adjunctive Treatment in Refractory Epilepsy.

English

Functional Status Among Patients With Rheumatic Diseases in the Slovak Republic

Value in Health

Occupational Health

English

PRS44 Cost Utility Analysis of Omalizumab Therapy for Severe Asthma Patients in Thailand

Value in Health

Occupational Health

English

Psy108 - Cost-Utility Analysis of Tocilizumab in Combination With Corticosteroids for the Treatment of Giant Cell Arteritis in Italian Patients

Value in Health

Occupational Health

English

Corticosteroids as Adjunctive Therapy With Antibiotics in the Treatment of Children With Septic Arthritis: A Meta-Analysis

Drug Design, Development and Therapy

Pharmaceutical Science

English